NOVEL ANTIMICROBIAL WITH ACTIVITY AGAINST MDRGRAM NEGATIVE BACTERIA
محل انتشار: بیست و سومین کنگره بین المللی میکروب شناسی ایران
سال انتشار: 1401
نوع سند: مقاله کنفرانسی
زبان: انگلیسی
مشاهده: 58
نسخه کامل این مقاله ارائه نشده است و در دسترس نمی باشد
- صدور گواهی نمایه سازی
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
MEDISM23_025
تاریخ نمایه سازی: 16 مهر 1401
چکیده مقاله:
Background and Aim : In recent years several novel antimicrobials with activity againstmultidrug-resistant Gram-negative bacilli have become available. Among the novel antimicrobialsare ceftazidime-avibactam, meropenem-varborbactam, imipenem-relebactam and cefiderocol. Thenovel antimicrobials rarely cover all bacterial resistance mechanisms and it is of utmost importanceto use them rationally. This presentation reviews the activity of the novel antimicrobial as well asthe potential for resistance development. Methods for reliable antimicrobial susceptibility testingare also presented, and it is emphasized that susceptibility cannot be assumed, but needs to beconfirmed by testing. The presentations also briefly discusses some antimicrobials that are still inthe development pipeline.Methods : -Results : -Conclusion : -
کلیدواژه ها:
نویسندگان
Christian G. Giske
Chairman of EUCAST, Karolinska Institute and Karolinska University Hospital Stockholm, Sweden